ALMIRALL, S.A. «...678910...» Page 9 out of 17 09/05/2022 06:58 ALMIRALL, S.A. Other relevant information La Sociedad comunica el calendario del dividendo flexible Register number: 16113 09/05/2022 06:55 ALMIRALL, S.A. Other relevant information La Sociedad comunica información relativa al dividendo flexible Register number: 16112 09/05/2022 06:51 ALMIRALL, S.A. On corporate governance Acuerdos adoptados por el Consejo de Administración Register number: 16111 09/05/2022 06:46 ALMIRALL, S.A. Announcement of general shareholders’ meeting Acuerdos adoptados en Junta General Ordinaria de la Sociedad Register number: 16110 11/04/2022 16:15 ALMIRALL, S.A. Other relevant information Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis Register number: 15561 30/03/2022 08:06 ALMIRALL, S.A. Other relevant information Presentation of 16 weeks data for Lebrikizumab ADvocate 1 & 2 Phase 3 studies: Webcast with analysts and institutional investors + Presentation Register number: 15269 26/03/2022 14:21 ALMIRALL, S.A. On business and financial situation 16 weeks data for Lebrikizumab ADvocate 1 & 2 Phase 3 studies has been announced today at the American Academy of Dermatology (AAD) Annual Meeting Register number: 15183 21/02/2022 07:00 ALMIRALL, S.A. Annual financial reports and audit reports La sociedad remite el Informe Financiero Anual del ejercicio 2021 Register number: 14138 21/02/2022 06:18 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad Register number: 14137 21/02/2022 06:15 ALMIRALL, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2021 Register number: 14136 Page 9 out of 17 «...678910...»